ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      87.33
      0.48%
      Bitcoin
      58,422.39
      -2.89%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. LianBio (LIAN)

      7. LianBio (LIAN) News

      LIAN

      LianBio (LIAN)

      LianBio
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LIAN
      DateTimeSourceHeadlineSymbolCompany
      08/14/20234:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
      08/14/20234:05PMGlobeNewswire Inc.LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:LIANLianBio
      08/03/20234:05PMGlobeNewswire Inc.LianBio Announces First Patient Treated in Phase 1 Trial of SHP2 Inhibitor BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR MutationsNASDAQ:LIANLianBio
      07/26/20238:30AMGlobeNewswire Inc.LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex BlepharitisNASDAQ:LIANLianBio
      07/18/20238:00AMGlobeNewswire Inc.LianBio Partner NANOBIOTIX Enters into License Agreement with Janssen for Radioenhancer NBTXR3, with LianBio Retaining Development and Commercialization Rights in Greater China, South Korea, Singapore and ThailandNASDAQ:LIANLianBio
      07/17/20236:00AMGlobeNewswire Inc.LianBio Announces Phase 3 EXPLORER-CN Data Accepted for Late-Breaking Presentation at the European Society of Cardiology Congress 2023NASDAQ:LIANLianBio
      07/12/20238:00AMGlobeNewswire Inc.LianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR MutationsNASDAQ:LIANLianBio
      06/26/20238:00AMGlobeNewswire Inc.LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in SingaporeNASDAQ:LIANLianBio
      06/23/20234:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LIANLianBio
      06/23/20234:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LIANLianBio
      06/23/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LIANLianBio
      06/23/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LIANLianBio
      06/08/20237:00AMGlobeNewswire Inc.LianBio Completes Enrollment in Pivotal Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex BlepharitisNASDAQ:LIANLianBio
      06/07/20236:21PMDow Jones NewsADRs End Mostly Lower, Oatly and LianBio Trade ActivelyNASDAQ:LIANLianBio
      06/06/20234:05PMGlobeNewswire Inc.LianBio Announces Topline Results from Phase 2a Proof of Concept Trial Evaluating Infigratinib in Patients with Gastric Cancer & Receipt of Breakthrough Therapy Designation in ChinaNASDAQ:LIANLianBio
      06/01/20234:15PMGlobeNewswire Inc.LianBio to Participate in Upcoming Investor ConferencesNASDAQ:LIANLianBio
      05/11/20234:34PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LIANLianBio
      05/11/20234:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LIANLianBio
      05/11/20234:15PMGlobeNewswire Inc.LianBio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:LIANLianBio
      05/11/20237:00AMGlobeNewswire Inc.LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of ChinaNASDAQ:LIANLianBio
      05/01/20237:29AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LIANLianBio
      04/28/20236:17AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LIANLianBio
      04/26/20236:51PMDow Jones NewsADRs End Mostly Lower, Dassault Systemes, LianBio Trade ActivelyNASDAQ:LIANLianBio
      04/26/20238:24AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:LIANLianBio
      04/26/20238:00AMGlobeNewswire Inc.LianBio Announces Positive Topline Results from Phase 3 EXPLORER-CN Trial Evaluating Mavacamten in Chinese PatientsNASDAQ:LIANLianBio
      04/21/20234:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LIANLianBio
      04/21/20238:15AMGlobeNewswire Inc.LianBio Promotes Pascal Qian to Chief Commercial OfficerNASDAQ:LIANLianBio
      04/21/20238:00AMGlobeNewswire Inc.LianBio Announces China National Medical Products Administration (NMPA) Acceptance with Priority Review of New Drug Application for Mavacamten for the Treatment of Patients with Obstructive Hypertrophic CardiomyopathyNASDAQ:LIANLianBio
      04/19/20234:18PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LIANLianBio
      03/31/20234:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LIANLianBio
       Showing the most relevant articles for your search:NASDAQ:LIAN